Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA to Revise 20-Year-Old ICH Reproductive Risks Guideline

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:Drug Industry Daily

The FDA published an ICH-developed revision to its industry guideline on the detection of reproductive risks in new drugs. Source: Drug Industry Daily

Continue ReadingFDA to Revise 20-Year-Old ICH Reproductive Risks Guideline

FDA Finalizes Guidance on Evaluating Drug Effects on Driving Ability

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:Drug Industry Daily

The FDA published guidance assisting sponsors in evaluating the effects of psychoactive drugs on the ability to operate a motor vehicle, saying reducing the incidence of accidents is a public…

Continue ReadingFDA Finalizes Guidance on Evaluating Drug Effects on Driving Ability

PTAB Sides With Amneal on Obviousness of Purdue’s Oxycontin Patent

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:Drug Industry Daily

The PTO’s Patent Trial and Appeal Board ruled against a Purdue Pharma patent on OxyContin, agreeing with Amneal Pharmaceuticals on the patent’s obviousness. Source: Drug Industry Daily

Continue ReadingPTAB Sides With Amneal on Obviousness of Purdue’s Oxycontin Patent

FDA Expands ANDA Prioritization Policy

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:Drug Industry Daily

Under a new category of generic ANDAs eligible for priority review, the FDA will prioritize applications likely to be ready for approval shortly after the six months of marketing exclusivity…

Continue ReadingFDA Expands ANDA Prioritization Policy

Danes Shutter Drug Importer Over Quality Issues

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:Drug Industry Daily

Danish drug regulators have moved to shut down a drug importer and repackager due to its inadequate quality control systems, the Danish Medicines Agency said. Source: Drug Industry Daily

Continue ReadingDanes Shutter Drug Importer Over Quality Issues

Siemens to Replace Healthineers CFO in Preparation for Listing

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:BioPharma

The public listing that is expected to value the business at around $46 billion. Source: BioSpace

Continue ReadingSiemens to Replace Healthineers CFO in Preparation for Listing

GlaxoSmithKline Poaches New CSO From Google's Calico

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:BioPharma

Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech. Source: BioSpace

Continue ReadingGlaxoSmithKline Poaches New CSO From Google's Calico

Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:BioPharma

The company will explore opportunity to close facilities during second half of 2019. Source: BioSpace

Continue ReadingRecipharm to End Operations at Two Swedish Facilities, 225 Employees Affected

German Biotech InflaRx Snags $100M in IPO

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:BioPharma

The company announced the pricing of its initial public offering of 6,667,000 common shares at an initial public offering price of $15.00 per common share. Source: BioSpace

Continue ReadingGerman Biotech InflaRx Snags $100M in IPO

After $40M Financing, Exonics Therapeutics to Start Hiring for Cambridge Lab

  • Post author:Sam
  • Post published:November 8, 2017
  • Post category:BioPharma

The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD. Source: BioSpace

Continue ReadingAfter $40M Financing, Exonics Therapeutics to Start Hiring for Cambridge Lab
  • Go to the previous page
  • 1
  • …
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.